Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.

Antimicrobial agents and chemotherapy - 1 Dec 1995

Lucier T S, Heitzman K, Liu S K, Hu P C

Abstract excerpt

Erythromycin is the drug of choice for treatment of Mycoplasma pneumoniae infections due to its susceptibility to low levels of this antibiotic. After exposure of susceptible strains to erythromycin in vitro and in vivo, mutants resistant to erythromycin and other macrolides were isolated. Their phenotypes have been characterized, but the genetic basis for resistance has never been determined. We isolated two...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Base Sequence
Share to Culture Media

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Molecular Sequence Data

Share to Mutation

Share to Nucleic Acid Conformation

Share to Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 8593017
DOI: 10.1128/AAC.39.12.2770
PMCID: PMC163027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.PMID 8593017Read ↗

In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae.Semantic proximity Read ↗

Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro.Semantic proximity Read ↗

Novel mechanisms of macrolide resistance revealed by in vitro selection and genome analysis in Mycoplasma pneumoniaeSemantic proximity Read ↗

High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.Semantic proximity Read ↗

Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.Semantic proximity Read ↗

Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.Semantic proximity Read ↗

Human vaginal Lactobacillus rhamnosus harbor mutation in 23S rRNA associated with erythromycin resistance.Semantic proximity Read ↗

New Resistance Mutations Linked to Decreased Susceptibility to Solithromycin in Streptococcus pneumoniae Revealed by Chemogenomic Screens.Semantic proximity Read ↗

Mutations in 23S rRNA and Ribosomal Protein L4 Account for Resistance in Pneumococcal Strains Selected In Vitro by Macrolide PassageSemantic proximity Read ↗

Identification of a single base change in ribosomal RNA leading to erythromycin resistance.Semantic proximity Read ↗

Characterization and Molecular Analysis of Macrolide-Resistant <i>Mycoplasma pneumoniae</i> Clinical Isolates Obtained in JapanSemantic proximity Read ↗

Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.